Ravindran A - Search Results

1

Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study.

Alders GL, Davis AD, MacQueen G, Strother SC, Hassel S, Zamyadi M, Sharma GB, Arnott SR, Downar J, Harris JK, Lam RW, Milev R, Müller DJ, Ravindran A, Kennedy SH, Frey BN, Minuzzi L, Hall GB; CAN-BIND Investigator Team. Alders GL, et al. Among authors: ravindran a. J Affect Disord. 2020 Mar 1;264:414-424. doi: 10.1016/j.jad.2019.11.068. Epub 2019 Nov 13. J Affect Disord. 2020. PMID: 31757619

2

Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.

Ravindran AV, Bialik RJ, Lapierre YD. Ravindran AV, et al. J Affect Disord. 1994 Jun;31(2):111-7. doi: 10.1016/0165-0327(94)90114-7. J Affect Disord. 1994. PMID: 8071473

3

Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin.

Ravindran AV, Bialik RJ, Brown GM, Lapierre YD. Ravindran AV, et al. J Affect Disord. 1994 Jun;31(2):119-23. doi: 10.1016/0165-0327(94)90115-5. J Affect Disord. 1994. PMID: 8071474

4

Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls.

Ravindran AV, Griffiths J, Merali Z, Anisman H. Ravindran AV, et al. J Affect Disord. 1999 Jan-Mar;52(1-3):1-10. doi: 10.1016/s0165-0327(98)00072-x. J Affect Disord. 1999. PMID: 10357012

5

A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.

Chouinard G, Saxena B, Bélanger MC, Ravindran A, Bakish D, Beauclair L, Morris P, Vasavan Nair NP, Manchanda R, Reesal R, Remick R, O'Neill MC. Chouinard G, et al. Among authors: ravindran a. J Affect Disord. 1999 Jul;54(1-2):39-48. doi: 10.1016/s0165-0327(98)00188-8. J Affect Disord. 1999. PMID: 10403145 Clinical Trial.

6

Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.

Zaharia MD, Ravindran AV, Griffiths J, Merali Z, Anisman H. Zaharia MD, et al. Among authors: ravindran av. J Affect Disord. 2000 Apr;58(1):1-10. doi: 10.1016/s0165-0327(99)00100-7. J Affect Disord. 2000. PMID: 10760553 Clinical Trial.

7

Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments.

Kennedy SH, Lam RW, Cohen NL, Ravindran AV; CANMAT Depression Work Group. Kennedy SH, et al. Among authors: ravindran av. Can J Psychiatry. 2001 Jun;46 Suppl 1:38S-58S. Can J Psychiatry. 2001. PMID: 11441771 Review.

8

Stress, coping, uplifts, and quality of life in subtypes of depression: a conceptual frame and emerging data.

Ravindran AV, Matheson K, Griffiths J, Merali Z, Anisman H. Ravindran AV, et al. J Affect Disord. 2002 Sep;71(1-3):121-30. doi: 10.1016/s0165-0327(01)00389-5. J Affect Disord. 2002. PMID: 12167508

9

Does fluoxetine influence major depression by modifying five-factor personality traits?

Du L, Bakish D, Ravindran AV, Hrdina PD. Du L, et al. J Affect Disord. 2002 Sep;71(1-3):235-41. doi: 10.1016/s0165-0327(01)00370-6. J Affect Disord. 2002. PMID: 12167523 Clinical Trial.

10

A dimensional approach to personality in atypical depression.

Chopra KK, Bagby RM, Dickens S, Kennedy SH, Ravindran A, Levitan RD. Chopra KK, et al. Among authors: ravindran a. Psychiatry Res. 2005 Apr 15;134(2):161-7. doi: 10.1016/j.psychres.2005.02.002. Psychiatry Res. 2005. PMID: 15840417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page